ATM and non-small cell lung carcinoma: An ATM/p53/Cox-2/PGE2 pathway described in non-small cell lung cancer (NSCLC) post-radiotherapy demonstrated that the ATM/p53 cascade increased production of COX-2/PGE2 in the presence of activated caspase-3 [37].